CAT
Caterpillar Inc.
CAT has the edge over PCAR overall, supported by stronger fundamentals and stronger modeled upside.
PCAR
PACCAR Inc
PCAR's outlook is improving, though it still trails on the overall score.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
PCAR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Unavailable |
PCAR's revenue and profitability are currently healthy, and its cash flow is stable. There isn't enough data to rate its balance sheet.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
PCAR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $61.46 | -42% |
| Fair | 14x | $74.66 | -30% |
| Forward | 16x | $106 | — |
| Current | 20x | $106 | — |
| Expensive | 22x | $118 | +11% |
Historical ranges are pointers, not guarantees.
PCAR's PE is in its expensive range at 20x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its fair range.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
PCAR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for PCAR, with profitability improving.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over PCAR on earnings, with more consistent year-over-year improvement.
PCAR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.63 | +26% |
| Q3 2026 | $5.25 | +2.9% |
| Q2 2026 | $4.76 | -18% |
| Q1 2026 | $4.70 | -29% |
| Q4 2025 | $4.51 | -43% |
| Q3 2025 | $5.10 | -43% |
| Q2 2025 | $5.83 | -38% |
| Q1 2025 | $6.59 | -32% |
| Q4 2024 | $7.90 | -9.8% |
PCAR's earnings per share have fallen from their peak: $5.25 over the past year, against $9.63 in early 2024.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over PCAR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over PCAR on profitability, with a higher operating margin.
PCAR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.9B | +19% |
| Q2 2026 | $7.5B | +0.5% |
| Q1 2026 | $6.8B | -8.9% |
| Q4 2025 | $6.8B | -14% |
| Q3 2025 | $6.7B | -19% |
| Q2 2025 | $7.5B | -14% |
| Q1 2025 | $7.4B | -15% |
| Q4 2024 | $7.9B | -13% |
PCAR's revenue has held roughly level: $7.9B last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +2.5 points |
| Q2 2026 | 13% | +0.6 points |
| Q1 2026 | 11% | +2.8 points |
| Q4 2025 | 10% | -4.2 points |
| Q3 2025 | 11% | -4.1 points |
| Q2 2025 | 12% | -4.2 points |
| Q1 2025 | 8.6% | -8.9 points |
| Q4 2024 | 15% | -3.5 points |
PCAR's operating margin was 14% last quarter, up 2.5 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
PCAR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $710.9M | -48% |
| Q2 2026 | $555.4M | -9.1% |
| Q1 2026 | $824.6M | +11% |
| Q4 2025 | $954.4M | -21% |
| Q3 2025 | $1.4B | +25% |
| Q2 2025 | $611.3M | +178% |
| Q1 2025 | $745.2M | -42% |
| Q4 2024 | $1.2B | +23% |
PCAR has the edge over CAT on cash flow, with stronger typical year-over-year growth.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over PCAR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
PCAR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +100K shares |
| 1 year | +0.2% | +1M shares |
| 3 years | +0.5% | +2.4M shares |
| 5 years | +1% | +5.3M shares |
| Available history | +1.2% | +6.5M shares |
PCAR has 528M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $800,000 |
| Q2 2026 | — |
| Q1 2026 | $4.8M |
| Q4 2025 | $900,000 |
| Q3 2025 | $200,000 |
| Q2 2025 | $30.7M |
| Q1 2025 | $4.3M |
| Q4 2024 | — |
PCAR has spent almost nothing on buybacks in the past year.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
PCAR Net Leverage
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PCAR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.5 | Neutral |
| Stochastic | 9.5 | Oversold |
PCAR's weekly RSI is 39 (neutral) and its Stochastic is 10 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
PCAR PE vs Industrials Sector
| Metric | PCAR | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 24x | 16% below |
| PE % | 76 | 58 | 18 pts above |
PCAR has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over PCAR on trend strength, trading above more of its moving averages.
PCAR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $107.1 | 0.7% below |
| 20 week MA | $118.8 | 10% below |
| 50 week MA | $118.4 | 10% below |
| 100 week MA | $108.7 | 2.2% below |
| 200 week MA | $101.1 | 5.1% above |
PCAR has fallen below most of its moving averages, though it's still 5.1% above its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over PCAR on returns for 2026, with the stronger performance.
PCAR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $52.9 | $57.4 | +8.4% |
| 2021 | $57.4 | $56.6 | -1.4% |
| 2022 | $56.6 | $67.0 | +18% |
| 2023 | $67.0 | $97.7 | +46% |
| 2024 | $97.7 | $104.6 | +7.1% |
| 2025 | $104.6 | $111.8 | +6.9% |
| 2026 YTD | $111.8 | $106.3 | -4.9% |
PCAR has finished higher in five of the last six years. It's down 4.9% so far in 2026.